Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. MSN Laboratories Private Limited (Formulations Division, Unit-II)
FDA Inspection
•MSN Laboratories Private Limited (Formulations Division, Unit-II)•February 28, 2018

MSN Laboratories Private Limited (Formulations Division, Unit-II) – FDA Inspection, Feb 28, 2018

Record Details

This FDA Inspection record concerns MSN Laboratories Private Limited (Formulations Division, Unit-II), with an inspection on February 28, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.

Company
MSN Laboratories Private Limited (Formulations Division, Unit-II)
Inspection Date
February 28, 2018
Product Type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • June P. Page (FDA Associated Person)
View Company Profile

ID · 3702691e-185c-482e-b4b5-4673f5f2dbf4

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1042443
FDA center
Human Drugs
Project area
Generic Drug Evaluation
Outcome
Form 483 issued

FDA Citations

8
  1. 21 CFR 211.100(b)SOPs not followed / documented
  2. 21 CFR 211.113(b)Procedures for sterile drug products
  3. 21 CFR 211.25(a)GMP Training Frequency
  4. 21 CFR 211.28(a)Protective Apparel Not Worn
  5. 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
  6. 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
  7. 21 CFR 211.80(a)Written Procedures Not Followed
  8. 21 CFR 211.84(c)(2)Containers sampled so as to prevent contamination

Full citation text and observation details available on the Dashboard.

Other FDA inspections of MSN Laboratories Private Limited (Formulations Division, Unit-II)

5
DateClassificationOfficeProject area
December 21, 2023VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 15, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
March 8, 2019Not classifiedOffice of Inspections and Investigations
July 21, 2017NAICenter for Drug Evaluation and ResearchDrug Quality Assurance
February 3, 2017VAIOffice of Inspections and InvestigationsGeneric Drug Evaluation
Other documents for MSN Laboratories Private Limited (Formulations Division, Unit-II)
  • FDA Inspection 1226168 - 2023-12-21
  • FDA Inspection 1110489 - 2019-11-15
  • FDA Inspection 1082118 - 2019-03-08
  • FDA Inspection 1023632 - 2017-07-21
  • FDA Inspection 1002592 - 2017-02-03

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore MSN Laboratories Private Limited (Formulations Division, Unit-II)
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.